Success Metrics

Clinical Success Rate
89.0%

Based on 65 completed trials

Completion Rate
89%(65/73)
Active Trials
11(10%)
Results Posted
57%(37 trials)
Terminated
8(7%)

Phase Distribution

Ph not_applicable
37
34%
Ph early_phase_1
2
2%
Ph phase_4
36
33%
Ph phase_2
12
11%
Ph phase_1
9
8%
Ph phase_3
10
9%

Phase Distribution

11

Early Stage

12

Mid Stage

46

Late Stage

Phase Distribution106 total trials
Early Phase 1First-in-human
2(1.9%)
Phase 1Safety & dosage
9(8.5%)
Phase 2Efficacy & side effects
12(11.3%)
Phase 3Large-scale testing
10(9.4%)
Phase 4Post-market surveillance
36(34.0%)
N/ANon-phased studies
37(34.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

65 of 78 finished

Non-Completion Rate

16.7%

13 ended early

Currently Active

11

trials recruiting

Total Trials

108

all time

Status Distribution
Active(13)
Completed(65)
Terminated(13)
Other(17)

Detailed Status

Completed65
unknown16
Terminated8
Recruiting7
Withdrawn5
Active, not recruiting4

Development Timeline

Analytics

Development Status

Total Trials
108
Active
11
Success Rate
89.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (1.9%)
Phase 19 (8.5%)
Phase 212 (11.3%)
Phase 310 (9.4%)
Phase 436 (34.0%)
N/A37 (34.9%)

Trials by Status

suspended11%
withdrawn55%
recruiting76%
completed6560%
active_not_recruiting44%
not_yet_recruiting22%
unknown1615%
terminated87%

Recent Activity

Clinical Trials (108)

Showing 20 of 108 trialsScroll for more
NCT05738148Phase 1

Vasopressin vs. Epinephrine During Neonatal Cardiopulmonary Resuscitation

Active Not Recruiting
NCT06112548Not Applicable

The Efficiency of Periarticular Multimodal Drug Injection in Pain Management Following Primary Unilateral TKA

Completed
NCT07144267Not Applicable

Comparison of Milrinone and Epinephrine on TAPSE

Not Yet Recruiting
NCT04432597Phase 1

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

Active Not Recruiting
NCT05488847Phase 4

Opioid-Free Pain Protocol After Shoulder Arthroplasty

Active Not Recruiting
NCT07092566Phase 3

R.E.C.K vs Exparel in Robotic Nephrectomy

Recruiting
NCT02118467Phase 4

Vasoactive Drugs in Intensive Care Unit

Recruiting
NCT06418308Phase 4

Intrathecal Dexmedetomidine vs Epinephrine

Recruiting
NCT06416969Early Phase 1

Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation

Recruiting
NCT03826524Phase 4

Epinephrine Dose: Optimal Versus Standard Evaluation Trial

Recruiting
NCT02692313Early Phase 1

Dose Response of Epinephrine

Completed
NCT02356159Phase 1

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

Completed
NCT02722746Phase 1

The Prevention of Hypotension After Epidural Analgesia After Major Surgery

Completed
NCT01059786Phase 2

Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia

Active Not Recruiting
NCT05972681Phase 4

The PAIN (Pelvic Area Injection for Numbness) Study

Recruiting
NCT03554473Phase 1

M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers

Completed
NCT04032119Phase 3

RCT of Gastric ESD With or Without Epineprhine Added Solution

Completed
NCT03476642Phase 4

Distribution, Pharmacokinetics and Extent of Sensory Blockade in ESP Blocks

Completed
NCT03030417Phase 1

Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas

Completed
NCT06264596Phase 3

Epinephrine in Irrigation Fluid for Visualization During Ankle Surgery

Withdrawn

Drug Details

Intervention Type
DRUG
Total Trials
108